Synthesis, cyclooxygenase inhibitory effects, and molecular modeling study of 4-aryl-5-(4-(methylsulfonyl)phenyl)-2-alkylthio and-2-alkylsulfonyl-1H-imidazole derivatives

被引:19
作者
Assadieskandar, Amir [1 ,2 ]
Amirhamzeh, Amirali [1 ,2 ]
Salehi, Marjan [1 ,2 ]
Ozadali, Keriman [3 ,4 ]
Ostad, Seyed Nasser [5 ,6 ]
Shafiee, Abbas [7 ,8 ]
Amini, Mohsen [1 ,2 ]
机构
[1] Univ Tehran Med Sci, Dept Med Chem, Fac Pharm, Tehran 14176, Iran
[2] Univ Tehran Med Sci, Drug Design & Dev Res Ctr, Tehran 14176, Iran
[3] Univ Alberta, Fac Pharm & Pharmaceut Sci, Katz Grp Ctr Pharm & Hlth Res 2142L, Edmonton, AB T6G 2E9, Canada
[4] Hacettepe Univ, Dept Pharmaceut Chem, Fac Pharm, TR-06100 Ankara, Turkey
[5] Univ Tehran Med Sci, Dept Pharmacol & Toxicol, Fac Pharm, Tehran, Iran
[6] Univ Tehran Med Sci, Rat Drug Use Res Ctr, Tehran, Iran
[7] Univ Tehran Med Sci, Dept Med Chem, Fac Pharm, Tehran 14176, Iran
[8] Univ Tehran Med Sci, Pharmaceut Sci Res Ctr, Tehran 14176, Iran
关键词
Cyclooxygenase; Human whole blood assay; Docking; Tautomerization; 2-Alkylthio-1H-imidazole; 2-Alkylsulfonyl-1H-imidazole; HYDE SCORING FUNCTION; BIOLOGICAL EVALUATION; SELECTIVE-INHIBITION; COX-2; INHIBITORS; SYNTHASE-1;
D O I
10.1016/j.bmc.2013.01.058
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
070307 [化学生物学]; 071010 [生物化学与分子生物学];
摘要
A series of 4-aryl-5-(4-(methylsulfonyl)phenyl)-2-alkylthio and 2-alkylsulfonyl-1H-imidazole derivatives were synthesized. All compounds were tested in human blood assay to determine COX-1 and COX-2 inhibitory potency and selectivity. Among the synthesized compounds, 2-alkylthio series were more potent and selective than 2-sulfonylalkyl derivatives. In molecular modeling, interaction of 2-sulfonylalkyl moiety with Arg120 in COX-1 and an extra hydrogen bond with Tyr341 in COX-2 increased the residence time of ligands in the active site in 2-sulfonylalkyl and 2-alkylthio analogs, respectively. (C) 2013 Elsevier Ltd. All rights reserved.
引用
收藏
页码:2355 / 2362
页数:8
相关论文
共 34 条
[1]
Antiinflammatory 4,5-diarylimidazoles as selective cyclooxygenase inhibitors [J].
Barta, TE ;
Stealey, MA ;
Collins, PW ;
Weier, RM .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1998, 8 (24) :3443-3448
[2]
Structural and functional basis of cyclooxygenase inhibition [J].
Blobaum, Anna L. ;
Marnett, Lawrence J. .
JOURNAL OF MEDICINAL CHEMISTRY, 2007, 50 (07) :1425-1441
[3]
A human whole blood assay for clinical evaluation of biochemical efficacy of cyclooxygenase inhibitors [J].
Brideau, C ;
Kargman, S ;
Liu, S ;
Dallob, AL ;
Ehrich, EW ;
Rodger, IW ;
Chan, CC .
INFLAMMATION RESEARCH, 1996, 45 (02) :68-74
[4]
Pharmacodynamic of cyclooxygenase inhibitors in humans [J].
Capone, Marta L. ;
Tacconelli, Stefania ;
Di Francesco, Luigia ;
Sacchetti, Andrea ;
Sciulli, Maria G. ;
Patrignani, Paola .
PROSTAGLANDINS & OTHER LIPID MEDIATORS, 2007, 82 (1-4) :85-94
[5]
Coxibs and cardiovascular side-effects:: From light to shadow [J].
Dogné, JM ;
Hanson, J ;
Supuran, C ;
Pratico, D .
CURRENT PHARMACEUTICAL DESIGN, 2006, 12 (08) :971-975
[6]
Molecular Basis for Cyclooxygenase Inhibition by the Non-steroidal Anti-inflammatory Drug Naproxen [J].
Duggan, Kelsey C. ;
Walters, Matthew J. ;
Musee, Joel ;
Harp, Joel M. ;
Kiefer, James R. ;
Oates, John A. ;
Marnett, Lawrence J. .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2010, 285 (45) :34950-34959
[7]
Synthesis and biological evaluation of 2-trifluoromethyl/sulfonamido-5,6-diaryl substituted imidazo[2,1-b]-1,3,4-thiadiazoles:: A novel class of cyclooxygenase-2 inhibitors [J].
Gadad, Andanappa K. ;
Palkar, Mahesh B. ;
Arland, K. ;
Noolvi, Malleshappa N. ;
Boreddy, Thippeswamy S. ;
Wagwade, J. .
BIOORGANIC & MEDICINAL CHEMISTRY, 2008, 16 (01) :276-283
[8]
Can drug removals involving cyclooxygenase-2 inhibitors be avoided? A plea for human pharmacology [J].
Hinz, Burkhard ;
Brune, Kay .
TRENDS IN PHARMACOLOGICAL SCIENCES, 2008, 29 (08) :391-397
[9]
Membrane-associated prostaglandin E synthase-1 is upregulated by proinflammatory cytokines in chondrocytes from patients with osteoarthritis [J].
Kojima, F ;
Naraba, H ;
Miyamoto, S ;
Beppu, M ;
Aoki, H ;
Kawai, S .
ARTHRITIS RESEARCH & THERAPY, 2004, 6 (04) :R355-R365
[10]
Structural basis for selective inhibition of cyclooxygenase-2 by anti-inflammatory agents [J].
Kurumbail, RG ;
Stevens, AM ;
Gierse, JK ;
McDonald, JJ ;
Stegeman, RA ;
Pak, JY ;
Gildehaus, D ;
Miyashiro, JM ;
Penning, TD ;
Seibert, K ;
Isakson, PC ;
Stallings, WC .
NATURE, 1996, 384 (6610) :644-648